Immune Clinical Trials in New York, New York
22 recruitingNew York, New York
Showing 1–20 of 22 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
NMDAR Autoimmune EncephalitisLGI1 Autoimmune Encephalitis
Hoffmann-La Roche152 enrolled93 locationsNCT05503264
Recruiting
Phase 3
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Interstitial Lung DiseasesSystemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim400 enrolled158 locationsNCT06806592
Recruiting
Phase 2Phase 3
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
DermatomyositisIdiopathic Inflammatory MyopathyAnti-synthetase Syndrome+5 more
Cabaletta Bio74 enrolled35 locationsNCT06154252
Recruiting
Phase 1
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
C3 GlomerulopathyImmune-complex-membranoproliferative Glomerulonephritis
Novartis Pharmaceuticals225 enrolled50 locationsNCT03955445
Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Hodgkin LymphomaNon-Hodgkin LymphomaHematologic Malignancies+14 more
Center for International Blood and Marrow Transplant Research99,999 enrolled142 locationsNCT01351545
Recruiting
Phase 1
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc.32 enrolled9 locationsNCT06680037
Recruiting
Phase 1Phase 2
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
HemoglobinopathiesMetabolic DisordersHematologic, Immune, or Bone Marrow Disorders+1 more
Washington University School of Medicine220 enrolled28 locationsNCT00920972
Recruiting
Phase 2
TReatment for ImmUne Mediated PathopHysiology
acute liver injuryImmune DysregulationHepatic Encephalopathy+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)163 enrolled24 locationsNCT04862221
Recruiting
Phase 2
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation
Blood CancerRefractory Immune Cytopenias
Memorial Sloan Kettering Cancer Center12 enrolled7 locationsNCT05873205
Recruiting
Phase 1
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Myasthenia GravisMuscle WeaknessAutoimmune Diseases+4 more
Arcellx, Inc.30 enrolled13 locationsNCT06626919
Recruiting
Not Applicable
WiseApp for Spanish Speakers Living With HIV
HIV InfectionsAcquired Immune Deficiency SyndromeSexually Transmitted Diseases, Viral
Columbia University248 enrolled2 locationsNCT05398185
Recruiting
Biologics And Clinical Immunology Cohort at Sinai
Autoimmune DiseasesImmunological DiseasePrimary Immune Deficiency
Icahn School of Medicine at Mount Sinai800 enrolled1 locationNCT04784364
Recruiting
Allergy and Immunology Natural History Study
Immune DeficiencyImmune Dysregulation DisorderAllergic Inflammation
Columbia University10,000 enrolled1 locationNCT05584488
Recruiting
Phase 1
A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors
Advanced Solid TumorMetastatic Solid TumorSolid Tumor+1 more
Exelixis75 enrolled10 locationsNCT06952010
Recruiting
Phase 1
A Study of SIPLIZUMAB in AILD and LT Patients
Autoimmune HepatitisCirrhosis, LiverPrimary Sclerosing Cholangitis+3 more
Elizabeth C. Verna8 enrolled1 locationNCT06455280
Recruiting
Phase 2
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
Immune System DiseasesPrimary Immune Regulatory DisorderAutoimmune Lymphoproliferative
Memorial Sloan Kettering Cancer Center39 enrolled12 locationsNCT05787574
Recruiting
Phase 1
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Cytomegalovirus InfectionsImmune DeficiencyBK Virus Infection+2 more
Columbia University18 enrolled1 locationNCT06926894
Recruiting
Autoimmune and Autoinflammatory Genetics Study
Rheumatic diseaseAutoimmune DiseaseAutoinflammatory Disease+1 more
NYU Langone Health1,500 enrolled2 locationsNCT06004349
Recruiting
Phase 2
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
EncephalitisAutoimmune Encephalitis
University of Utah116 enrolled39 locationsNCT04372615